Brief: Hansa Biopharma Q3 Net Income SEK -148.3 Million
30/10/2025 06:01
Oct 30 (Reuters) - Hansa Biopharma Q3 adjusted EPS SEK -1.75. Q3 EBIT SEK -147.6 million Q3 cash & investments SEK 252.1 million Q3 revenue SEK 30.8 million
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS